4792 studies found for:    "Kidney Diseases"
Show Display Options
Rank Status Study
21 Completed Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: Darbepoetin Alfa
22 Active, not recruiting VA NEPHRON-D: Diabetes iN Nephropathy Study
Conditions: Kidney Disease;   Nephropathy;   Type 2 Diabetes
Interventions: Drug: losartan;   Drug: lisinopril
23 Completed Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: Cinacalcet HCl
24 Enrolling by invitation Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease
Conditions: Cardiovascular Disease;   Chronic Kidney Disease;   Chronic Renal Disease;   Hypertension
Intervention: Behavioral: exercise aerobic
25 Not yet recruiting Lanreotide In Polycystic Kidney Disease Study
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD
Interventions: Drug: Lanreotide;   Drug: saline
26 Recruiting Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Conditions: Anemia;   Chronic Kidney Disease;   Kidney Disease
Interventions: Drug: darbepoetin alfa QW;   Drug: darbepoetin alfa Q2W
27 Recruiting Pilot Study of Velcade® in IgA Nephropathy
Conditions: Chronic Kidney Disease;   IgA Nephropathy
Intervention: Drug: Bortezomib (Velcade®)
28 Completed START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism
Conditions: Kidney Disease;   Secondary Hyperparathyroidism;   Chronic Kidney Disease
Intervention: Drug: Sensipar
29 Completed Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
Conditions: Radiocontrast-Induced Nephropathy;   Chronic Kidney Disease;   Diabetes Mellitus
Interventions: Drug: N-acetylcysteine;   Drug: Placebo
30 Terminated
Has Results
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Conditions: Proteinuric Kidney Disease;   Diabetic Nephropathy;   Hypertensive Nephrosclerosis;   IgA Nephropathy;   Focal Segmental Glomerulosclerosis;   Glomerulopathy (Obesity-associated);   Glomerulonephritis, Membranous
Interventions: Drug: Aliskiren;   Drug: Valsartan
31 Recruiting Improving Evidence-Based Primary Care for Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Chronic Kidney Insufficiency;   Chronic Renal Diseases;   Chronic Renal Insufficiency;   Kidney Insufficiency, Chronic
Interventions: Other: Facilitated Clinical Decision Support;   Other: Clinical Decision Support Only
32 Completed
Has Results
The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Interventions: Drug: Zemplar (paricalcitol ) capsules;   Drug: Zemplar (paricalcitol) capsules;   Drug: Placebo
33 Enrolling by invitation Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
34 Completed Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Tetracosactin
35 Recruiting Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
Conditions: Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 3
Intervention: Drug: Aspirin
36 Completed Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function
Conditions: Mild Nephropathy;   Moderate Nephropathy;   Diabetes Mellitus
Intervention: Drug: Technosphere Inhalation Powder
37 Completed Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions: Drug: Sirolimus;   Other: Standard
38 Terminated Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions: Drug: Sirolimus;   Drug: conventional therapy
39 Active, not recruiting Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency
Condition: Autosomal Dominant Polycystic Kidney Disease.
Interventions: Drug: Octreotide-LAR;   Other: Saline solution.
40 Not yet recruiting The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Everolimus;   Drug: Calcineurin inhibitors maintenance

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years